跳至主要内容
临床试验/JPRN-UMIN000000488
JPRN-UMIN000000488已完成2 期

A phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis - Hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis

Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital0 个研究点目标入组 25 人开始时间: 2006年9月12日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Prior chemotherapy with cisplatin for hepatocellular carcinoma 2) Prior radiotherapy, transcatheter arterial chemoembolization, and hepatic arterial chemotherapy for portal vein tumor thrombosis of hepatocellular carcinoma 3) Refractory pleural effusion or ascites 4) Distant metastases 5) Allergic reaction to iodine contrast material 6) Severe renal disease 7) Severe heart disease 8) Active infection excluding hepatitis B or C viral infection 9) Active concomitant malignancy 10) Severe mental disorder 11) Severe allergic reaction to drug 12) Pregnant and lactating females; females of childbearing age unless using effective contraception

研究者

发起方
Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital

相似试验

A phase II trial of hepatic arterial infusion... | 临床试验